Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis

Experimental Biology and Medicine

Volumn 237, Issue 7, 2012, Pages 803-810

  Roos, Per M ^a,b   Lierhagen, Syverin ^c   Flaten, Trond Peder ^c   Syversen, Tore ^c   Vesterberg, Olof ^d   Nordberg, Monica ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

ALS; CSF; HR ICP MS; Manganese; Plasma

Indexed keywords

MANGANESE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; BRAIN ELECTROPHYSIOLOGY; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; MALE; MANGANESE; MASS SPECTROMETRY; MIDDLE AGED; QUALITY CONTROL;

EID: 84865312264     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2012.011396     Document Type: Article

References (41)

1. Cannon JR, Greenamyre JT. The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicol Sci 2011;124:225-50
2. Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 2009;65(Suppl. 1):S3-9.
3. Roos PM, Vesterberg O, Nordberg M. Metals in motor neuron diseases. Exp Biol Med (Maywood) 2006;231:1481-7
4. Aschner M, Guilarte TR, Schneider JS, Zheng W. Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharmacol 2007;221:131-47
5. Yase Y. The pathogenesis of amyotrophic lateral sclerosis. Lancet 1972;2:292-6
6. Aschner M. Astrocyte metallothioneins (MTs) and their neuroprotective role. Ann N Y Acad Sci 1997;825:334-47
7. Aschner M, Dorman DC. Manganese: pharmacokinetics and molecular mechanisms of brain uptake. Toxicol Rev 2006;25:147-54
8. Zheng W, Aschner M, Ghersi-Egea JF. Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol Appl Pharmacol 2003;192:1-11
9. Basun H, Forssell LG, Wetterberg L, Winblad B. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J Neural Transm Park Dis Dement Sect 1991;3:231-58
10. Kapaki E, Zournas C, Kanias G, Zambelis T, Kakami A, Papageorgiou C. Essential trace element alterations in amyotrophic lateral sclerosis. J Neurol Sci 1997;147:171-5
11. Michalke B, Nischwitz V. Review on metal speciation analysis in cerebrospinal fluid-current methods and results: a review. Anal Chim Acta 2010;682:23 36
12. Nischwitz V, Berthele A, Michalke B. Speciation analysis of selected metals and determination of their total contents in paired serum and cerebrospinal fluid samples: an approach to investigate the permeability of the human blood-cerebrospinal fluid-barrier. Anal Chim Acta 2008;627:258-69
13. Miller RG, Munsat TL, Swash M, Brooks BR. Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research. J Neurol Sci 1999;169:2-12
14. Higashihara M, Sonoo M. Electrodiagnosis of ALS. Brain Nerve 2007;59:1031-41
15. Gellein K, Roos PM, Evje L, Vesterberg O, Flaten TP, Nordberg M, Syversen T. Separation of proteins including metallothionein in cerebrospinal fluid by size exclusion HPLC and determination of trace elements by HR-ICP-MS. Brain Res 2007;1174:136-42
16. Rodushkin I, Engstrom E, Stenberg A, Baxter DC. Determination of low-abundance elements at ultra-trace levels in urine and serum by inductively coupled plasma-sector field mass spectrometry. Anal Bioanal Chem 2004;380:247-57
17. Siegel S, Castellan NJ. Nonparametric Statistics for the Behavioral Sciences. New York: McGraw-Hill, 1988.
18. Šaric M, Lucchini R. Manganese. In: Nordberg GF, Fowler BA, Nordberg M, Friberg LT, eds. Handbook on the Toxicology of Metals. 3rd edn. Amsterdam: Elsevier Academic Press 2007
19. Fitsanakis VA, Piccola G, Marreilha dos Santos AP, Aschner JL, Aschner M. Putative proteins involved in manganese transport across the blood brain barrier. Hum Exp Toxicol 2007;26:295-302
20. West AK, Hidalgo J, Eddins D, Levin ED, Aschner M. Metallothionein in the central nervous system: roles in protection, regeneration and cognition. Neurotoxicology 2008;29:489-503
21. Cotzias GC, Papavasiliou PS. State of binding of natural manganese in human cerebrospinal fluid, blood and plasma. Nature 1962;195:823-4
22. Jimenez-Jimenez FJ, Molina JA, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, de Bustos F, Martínez-Salio A, Ortí-Pareja M, Zurdo M, Martínez-Para MC. Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease. J Neural Transm 1998;105:497-505
23. Michalke B, Halbach S, Nischwitz V. Speciation and toxicological relevance of manganese in humans. J Environ Monit 2007;9:650-6.
24. Gellein K, Skogholt JH, Aaseth J, Thoresen GB, Lierhagen S, Steinnes E, Syversen T, Flaten TP. Trace elements in cerebrospinal fluid and blood from patients with a rare progressive central and peripheral demyelinating disease. J Neurol Sci 2008;266:70-8.
25. Melo TM, Larsen C, White LR, Aasly J, Sjobakk TE, Flaten TP, Sonnewald U, Syversen T. Manganese, copper, and zinc in cerebrospinal fluid from patients with multiple sclerosis. Biol Trace Elem Res 2003;93:1-8
26. Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and microvascular disease systematic review and meta-analysis. Neurobiol Aging 2009;30:337-52.
27. Bock NA, Paiva FF, Nascimento GC, Newman JD, Silva AC. Cerebrospinal fluid to brain transport of manganese in a non-human primate revealed by MRI. Brain Res 2008;1198:160-70.
28. Erikson KM, Dorman DC, Lash LH, Aschner M. Duration of airborne-manganese exposure in rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity. Neurotoxicology 2008;29:377-85
29. Nordberg M, Nordberg GF. Toxicological aspects of metallothionein. Cell Mol Biol (Noisy-le-grand) 2000;46:451-63
30. Morahan JM, Yu B, Trent RJ, Pamphlett R. Are metallothionein genes silenced in ALS? Toxicol Lett 2007;168:83-7
31. Sillevis Smitt PA, Mulder TP, Verspaget HW, Blaauwgeers HG, Troost D, de Jong JM. Metallothionein in amyotrophic lateral sclerosis. Biol Signals 1994;3:193-7
32. Sillevis Smitt PA, van Beek H, Baars AJ, Troost D, Louwerse ES, Krops-Hermus AC, de Wolff FA, de Jong JM. Increased metallothionein in the liver and kidney of patients with amyotrophic lateral sclerosis. Arch Neurol 1992;49:721-4
33. Burton NC, Guilarte TR. Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates. Environ Health Perspect 2009;117:325-32
34. Yokel RA, Crossgrove JS. Manganese toxicokinetics at the blood-brain barrier. Res Rep Health Eff Inst 2004;119:7-58; discussion 9-73.
35. Wang X, Miller DS, Zheng W. Intracellular localization and subsequent redistribution of metal transporters in a rat choroid plexus model following exposure to manganese or iron. Toxicol Appl Pharmacol 2008;230:167-74
36. Sung JH, Kim CY, Yang SO, Khang HS, Cheong HK, Lee JS, Song CW Park JD, Han JH, Chung YH, Choi BS, Kwon IH, Cho MH, Yu IJ. Changes in blood manganese concentration and MRI t1 relaxation time during 180 days of stainless steel welding-fume exposure in cynomolgus monkeys. Inhal Toxicol 2007;19:47-55
37. Park NH, Park JK, Choi Y, Yoo CI, Lee CR, Lee H, Kim HK, Kim SR, Jeong TH, Park J, Yoon CS, Kim Y. Whole blood manganese correlates with high signal intensities on T1-weighted MRI in patients with liver cirrhosis. Neurotoxicology 2003;24:909-15
38. Fisman M. Hepatic ultrastructural change and liver dysfunction in amyotrophic lateral sclerosis. Arch Neurol 1987;44-997
39. Masui Y, Mozai T, Kakehi K. Functional and morphometric study of the liver in motor neuron disease. J Neurol 1985;232:15-9
40. Nakano Y, Hirayama K, Terao K. Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral sclerosis. Arch Neurol 1987;44:103-6
41. Miyata S, Nakamura S, Nagata H, Kameyama M. Increased manganese level in spinal cords of amyotrophic lateral sclerosis determined by radiochemical neutron activation analysis. J Neurol Sci 1983;61:283-93